IBDEI068 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6061,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,6061,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,6062,0)
 ;;=E87.1^^39^432^18
 ;;^UTILITY(U,$J,358.3,6062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6062,1,3,0)
 ;;=3^Hypo-osmolality and Hyponatremia
 ;;^UTILITY(U,$J,358.3,6062,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,6062,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,6063,0)
 ;;=E87.2^^39^432^1
 ;;^UTILITY(U,$J,358.3,6063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6063,1,3,0)
 ;;=3^Acidosis
 ;;^UTILITY(U,$J,358.3,6063,1,4,0)
 ;;=4^E87.2
 ;;^UTILITY(U,$J,358.3,6063,2)
 ;;=^5003020
 ;;^UTILITY(U,$J,358.3,6064,0)
 ;;=E87.3^^39^432^3
 ;;^UTILITY(U,$J,358.3,6064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6064,1,3,0)
 ;;=3^Alkalosis
 ;;^UTILITY(U,$J,358.3,6064,1,4,0)
 ;;=4^E87.3
 ;;^UTILITY(U,$J,358.3,6064,2)
 ;;=^5003021
 ;;^UTILITY(U,$J,358.3,6065,0)
 ;;=E87.4^^39^432^24
 ;;^UTILITY(U,$J,358.3,6065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6065,1,3,0)
 ;;=3^Mixed Acid-Base Balance Disorder
 ;;^UTILITY(U,$J,358.3,6065,1,4,0)
 ;;=4^E87.4
 ;;^UTILITY(U,$J,358.3,6065,2)
 ;;=^5003022
 ;;^UTILITY(U,$J,358.3,6066,0)
 ;;=E86.9^^39^432^31
 ;;^UTILITY(U,$J,358.3,6066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6066,1,3,0)
 ;;=3^Volume Depletion,Unspec
 ;;^UTILITY(U,$J,358.3,6066,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,6066,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,6067,0)
 ;;=E86.0^^39^432^6
 ;;^UTILITY(U,$J,358.3,6067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6067,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,6067,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,6067,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,6068,0)
 ;;=E86.1^^39^432^22
 ;;^UTILITY(U,$J,358.3,6068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6068,1,3,0)
 ;;=3^Hypovolemia
 ;;^UTILITY(U,$J,358.3,6068,1,4,0)
 ;;=4^E86.1
 ;;^UTILITY(U,$J,358.3,6068,2)
 ;;=^332744
 ;;^UTILITY(U,$J,358.3,6069,0)
 ;;=E87.70^^39^432^11
 ;;^UTILITY(U,$J,358.3,6069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6069,1,3,0)
 ;;=3^Fluid Overload,Unspec
 ;;^UTILITY(U,$J,358.3,6069,1,4,0)
 ;;=4^E87.70
 ;;^UTILITY(U,$J,358.3,6069,2)
 ;;=^5003023
 ;;^UTILITY(U,$J,358.3,6070,0)
 ;;=E87.5^^39^432^14
 ;;^UTILITY(U,$J,358.3,6070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6070,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,6070,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,6070,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,6071,0)
 ;;=E87.6^^39^432^20
 ;;^UTILITY(U,$J,358.3,6071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6071,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,6071,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,6071,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,6072,0)
 ;;=E87.8^^39^432^8
 ;;^UTILITY(U,$J,358.3,6072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6072,1,3,0)
 ;;=3^Electrolyte & Fluid Balance Disorders NEC
 ;;^UTILITY(U,$J,358.3,6072,1,4,0)
 ;;=4^E87.8
 ;;^UTILITY(U,$J,358.3,6072,2)
 ;;=^5003026
 ;;^UTILITY(U,$J,358.3,6073,0)
 ;;=E26.81^^39^432^5
 ;;^UTILITY(U,$J,358.3,6073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6073,1,3,0)
 ;;=3^Bartter's Syndrome
 ;;^UTILITY(U,$J,358.3,6073,1,4,0)
 ;;=4^E26.81
 ;;^UTILITY(U,$J,358.3,6073,2)
 ;;=^329906
 ;;^UTILITY(U,$J,358.3,6074,0)
 ;;=E23.2^^39^432^7
 ;;^UTILITY(U,$J,358.3,6074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6074,1,3,0)
 ;;=3^Diabetes Insipidus
 ;;^UTILITY(U,$J,358.3,6074,1,4,0)
 ;;=4^E23.2
 ;;^UTILITY(U,$J,358.3,6074,2)
 ;;=^33572
 ;;^UTILITY(U,$J,358.3,6075,0)
 ;;=E83.41^^39^432^15
 ;;^UTILITY(U,$J,358.3,6075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6075,1,3,0)
 ;;=3^Hypermagnesemia
 ;;^UTILITY(U,$J,358.3,6075,1,4,0)
 ;;=4^E83.41
 ;;^UTILITY(U,$J,358.3,6075,2)
 ;;=^5003002
 ;;^UTILITY(U,$J,358.3,6076,0)
 ;;=E21.3^^39^432^17
 ;;^UTILITY(U,$J,358.3,6076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6076,1,3,0)
 ;;=3^Hyperparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,6076,1,4,0)
 ;;=4^E21.3
 ;;^UTILITY(U,$J,358.3,6076,2)
 ;;=^331438
 ;;^UTILITY(U,$J,358.3,6077,0)
 ;;=E83.42^^39^432^21
 ;;^UTILITY(U,$J,358.3,6077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6077,1,3,0)
 ;;=3^Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,6077,1,4,0)
 ;;=4^E83.42
 ;;^UTILITY(U,$J,358.3,6077,2)
 ;;=^5003003
 ;;^UTILITY(U,$J,358.3,6078,0)
 ;;=N25.1^^39^432^25
 ;;^UTILITY(U,$J,358.3,6078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6078,1,3,0)
 ;;=3^Nephrogenic Diabetes Insipidus
 ;;^UTILITY(U,$J,358.3,6078,1,4,0)
 ;;=4^N25.1
 ;;^UTILITY(U,$J,358.3,6078,2)
 ;;=^5015616
 ;;^UTILITY(U,$J,358.3,6079,0)
 ;;=E27.49^^39^432^2
 ;;^UTILITY(U,$J,358.3,6079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6079,1,3,0)
 ;;=3^Adrenocortical Insufficiency,Other
 ;;^UTILITY(U,$J,358.3,6079,1,4,0)
 ;;=4^E27.49
 ;;^UTILITY(U,$J,358.3,6079,2)
 ;;=^5002743
 ;;^UTILITY(U,$J,358.3,6080,0)
 ;;=E72.09^^39^432^4
 ;;^UTILITY(U,$J,358.3,6080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6080,1,3,0)
 ;;=3^Amino-Acid Transport Disorders,Other
 ;;^UTILITY(U,$J,358.3,6080,1,4,0)
 ;;=4^E72.09
 ;;^UTILITY(U,$J,358.3,6080,2)
 ;;=^5002895
 ;;^UTILITY(U,$J,358.3,6081,0)
 ;;=N25.89^^39^432^23
 ;;^UTILITY(U,$J,358.3,6081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6081,1,3,0)
 ;;=3^Impaired Renal Tubular Function Disorders,Other
 ;;^UTILITY(U,$J,358.3,6081,1,4,0)
 ;;=4^N25.89
 ;;^UTILITY(U,$J,358.3,6081,2)
 ;;=^5015618
 ;;^UTILITY(U,$J,358.3,6082,0)
 ;;=E26.89^^39^432^12
 ;;^UTILITY(U,$J,358.3,6082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6082,1,3,0)
 ;;=3^Hyperaldosteronism,Other
 ;;^UTILITY(U,$J,358.3,6082,1,4,0)
 ;;=4^E26.89
 ;;^UTILITY(U,$J,358.3,6082,2)
 ;;=^5002737
 ;;^UTILITY(U,$J,358.3,6083,0)
 ;;=N25.81^^39^432^29
 ;;^UTILITY(U,$J,358.3,6083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6083,1,3,0)
 ;;=3^Secondary Hyperparathyroidism of Renal Origin
 ;;^UTILITY(U,$J,358.3,6083,1,4,0)
 ;;=4^N25.81
 ;;^UTILITY(U,$J,358.3,6083,2)
 ;;=^5015617
 ;;^UTILITY(U,$J,358.3,6084,0)
 ;;=E22.2^^39^432^28
 ;;^UTILITY(U,$J,358.3,6084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6084,1,3,0)
 ;;=3^SIADH
 ;;^UTILITY(U,$J,358.3,6084,1,4,0)
 ;;=4^E22.2
 ;;^UTILITY(U,$J,358.3,6084,2)
 ;;=^5002718
 ;;^UTILITY(U,$J,358.3,6085,0)
 ;;=E87.79^^39^432^10
 ;;^UTILITY(U,$J,358.3,6085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6085,1,3,0)
 ;;=3^Fluid Overload,Other
 ;;^UTILITY(U,$J,358.3,6085,1,4,0)
 ;;=4^E87.79
 ;;^UTILITY(U,$J,358.3,6085,2)
 ;;=^5003025
 ;;^UTILITY(U,$J,358.3,6086,0)
 ;;=E21.0^^39^432^27
 ;;^UTILITY(U,$J,358.3,6086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6086,1,3,0)
 ;;=3^Primary Hyperparathyroidism
 ;;^UTILITY(U,$J,358.3,6086,1,4,0)
 ;;=4^E21.0
 ;;^UTILITY(U,$J,358.3,6086,2)
 ;;=^331439
 ;;^UTILITY(U,$J,358.3,6087,0)
 ;;=E87.71^^39^432^30
 ;;^UTILITY(U,$J,358.3,6087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6087,1,3,0)
 ;;=3^Transfusion Associated Circulatory Overload
 ;;^UTILITY(U,$J,358.3,6087,1,4,0)
 ;;=4^E87.71
 ;;^UTILITY(U,$J,358.3,6087,2)
 ;;=^5003024
 ;;^UTILITY(U,$J,358.3,6088,0)
 ;;=D63.1^^39^433^1
 ;;^UTILITY(U,$J,358.3,6088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6088,1,3,0)
 ;;=3^Anemia in Chronic Kidney Disease
 ;;^UTILITY(U,$J,358.3,6088,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,6088,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,6089,0)
 ;;=I12.0^^39^433^9
 ;;^UTILITY(U,$J,358.3,6089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6089,1,3,0)
 ;;=3^HTN w/ CKD w/ Stage 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,6089,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,6089,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,6090,0)
 ;;=I95.1^^39^433^10
 ;;^UTILITY(U,$J,358.3,6090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6090,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,6090,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,6090,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,6091,0)
 ;;=I95.89^^39^433^11
 ;;^UTILITY(U,$J,358.3,6091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6091,1,3,0)
 ;;=3^Hypotension,Other
